Medigen to hold small Phase 3 trial of its COVID-19 vaccine in Paraguay
07/20/2021 07:01 PM
Medigen Vaccine Biologics Corp. announced Tuesday that it has received permission to hold a 1,000-person Phase 3 clinical trial in Paraguay for its COVID-19 vaccine, which was granted emergency use authorization (EUA) in Taiwan the day before.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
African swine fever virus related to China, Vietnam strains: Ministry
10/31/2025 07:11 PM - Society
EVA Air curbs sick leave penalties following flight attendant's death
10/31/2025 06:36 PM - Business
U.S. dollar closes higher on Taipei forex market
10/31/2025 06:22 PM - Politics
President Lai attends commissioning of M1A2T tank battalion
10/31/2025 06:16 PM - Business
Taiwan, U.S. officials hold talks at APEC: Source
10/31/2025 05:21 PM